Patents by Inventor Fabio Bignotti

Fabio Bignotti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050147836
    Abstract: A chemical sensor for detecting an analyte in a fluid, useful for the production of an apparatus for the analysis of odours (an electronic nose), comprises a film of composite material formed by a matrix of a non-conductive polymer constituted by a polyamidoamine and a conductive filler, e.g. carbon black. In preferred embodiments, the polyamidoamine is formed as the adduct of bisacrylamidoacetic (BAC) and N, N?-dimethylethylenediamide (DMEDA) else N, N?-ethlenediaminoaceticacid (EDDA), and can include copper or cobalt ions as complexes.
    Type: Application
    Filed: March 18, 2003
    Publication date: July 7, 2005
    Inventors: Luciana Sartore, Maurizio Penco, Fabio Bignotti, Giorgio Sberveglieri
  • Publication number: 20040166158
    Abstract: PEG-chitosan conjugates comprising chitosan and polyethylene glycol moieties or derivatives thereof which are bonded together and their use in medicine is described. In one embodiment, the conjugate comprises a chitosan moiety or a derivative thereof and a polyethylene glycol moiety or a derivative thereof which are bonded together via the amino function on the chitosan by the use of an activated chitosan species. In another embodiment, the conjugate comprises a chitosan moiety or a derivative thereof and a polyethylene glycol moiety or a derivative thereof which are bonded together, the chitosan portion of the conjugate having a molecular weight in the range of from 10 kilodaltons to 1000 kilodaltons.
    Type: Application
    Filed: February 25, 2004
    Publication date: August 26, 2004
    Applicant: West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited.
    Inventors: Stanley Stewart Davis, Wu Lin, Fabio Bignotti, Paolo Ferruti
  • Publication number: 20040086481
    Abstract: A nucleic acid complex for delivering a nucleic acid or a derivative thereof to a cell comprises the components: A. a nucleic acid or a derivative thereof; B. a cationic polymer; and C. a preformed polyethylene glycol-cationic polymer copolymer. The complex has a conformation in which the nucleic acid or derivative thereof is condensed and wherein component C is bound to component A such that the poylethylene glycol groups of component C are located at the surface of the complex. The complexes which are stable to aggregation are useful for the delivery of nucleic acids or derivatives thereof to cells in biological systems.
    Type: Application
    Filed: April 9, 2003
    Publication date: May 6, 2004
    Inventors: Martin Charles Garnett, Nicolas Andrew Jones, Benjamin James Rackstraw, Fabio Bignotti
  • Patent number: 6730735
    Abstract: PEG-chitosan conjugates comprising chitosan and polyethylene glycol moieties or derivatives thereof which are bonded together and their use in medicine is described. In one embodiment, the conjugate comprises a chitosan moiety or a derivative thereof and a polyethylene glycol moiety or a derivative thereof which are bonded together via the amino function on the chitosan by the use of an activated chitosan species. In another embodiment, the conjugate comprises a chitosan moiety or a derivative thereof and a polyethylene glycol moiety or a derivative thereof which are bonded together, the chitosan portion of the conjugate having a molecular weight in the range of from 10 kilodaltons to 1000 kilodaltons.
    Type: Grant
    Filed: January 24, 2003
    Date of Patent: May 4, 2004
    Assignee: West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited
    Inventors: Stanley Stewart Davis, Wu Lin, Fabio Bignotti, Paolo Ferruti
  • Patent number: 6677438
    Abstract: A process for attaching a polyethylene glycol compound to a macromolecule to prepare a conjugate or adduct between the polyethylene glycol compound and the macromolecule is described. The process comprises the steps of (1) preparing an activated PEG or an activated PEG derivative by incorporating an acrylic ester, an acrylic thioester or an acrylamido group into the PEG or PEG derivative; (2) reacting the activated PEG or PEG derivative with a macromolecular material comprising one or more sulphydryl groups, primary amino groups and/or secondary amino groups and (3) recovering the conjugate of the PEG or PEG derivative and the macromolecular material.
    Type: Grant
    Filed: July 21, 2000
    Date of Patent: January 13, 2004
    Assignees: University of Nottingham, Universita Degli Studi di Brescia
    Inventors: Martin Charles Garnett, Stanley Stewart Davis, Fabio Bignotti, Paolo Ferruti
  • Publication number: 20030166783
    Abstract: PEG-chitosan conjugates comprising chitosan and polyethylene glycol moieties or derivatives thereof which are bonded together and their use in medicine is described. In one embodiment, the conjugate comprises a chitosan moiety or a derivative thereof and a polyethylene glycol moiety or a derivative thereof which are bonded together via the amino function on the chitosan by the use of an activated chitosan species. In another embodiment, the conjugate comprises a chitosan moiety or a derivative thereof and a polyethylene glycol moiety or a derivative thereof which are bonded together, the chitosan portion of the conjugate having a molecular weight in the range of from 10 kilodaltons to 1000 kilodaltons.
    Type: Application
    Filed: January 24, 2003
    Publication date: September 4, 2003
    Applicant: West Pharmaceutical Services Drug Delivery and Clinical Research Center Limited
    Inventors: Stanley Stewart Davis, Wu Lin, Fabio Bignotti, Paolo Ferruti
  • Patent number: 6413941
    Abstract: A composition for delivering a biologically active polyanionic molecule comprising a linear polymer with a backbone comprising amido and tertiary amino groups arranged regularly on the backbone and biologically active polyanionic molecule bound to the polymer. Preferably, the linear polymer comprises a poly(amidoamine). Preferably, the biologically active polyanionic molecule is a nucleic acid, more preferably a DNA. The compositions are useful for delivering nucleic acids to a cell in a cell transformation, transfection or gene therapy method.
    Type: Grant
    Filed: August 3, 1998
    Date of Patent: July 2, 2002
    Assignee: West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited
    Inventors: Martin Charles Garnett, Fiona Caroline Maclaughlin, Stanley Stewart Davis, Fabio Bignotti, Paolo Ferruti
  • Patent number: 5698661
    Abstract: Polyesterpolycarbonates of formula (I) ##STR1## wherein a is an integer from 2 to 300; R.sub.1 and R.sub.2, which can be the same or different, are each a polyester residue of formula (II) ##STR2## with x and y being integers from 0 to 100, and the ratio of (x/x+y)*100 being between 0 and 100, with the proviso that x and y are not 0 at the same time; R.sub.3 and R.sub.4 being aliphatic hydrocarbon residues of 1 to 4 carbon atoms; R.sub.5 being an aliphatic hydrocarbon residue having from 2 to 18 carbon atoms or a cycloaliphatic hydrocarbon residue having from 3 to 8 carbon atoms; or a polyoxyalkylene residue of formula (III): ##STR3## wherein R.sub.6 is hydrogen or methyl, n is an integer from 1 to 3 and m is an integer from 1 to 200; and the two --R.sub.3 --COO and --R.sub.4 --COO groups are randomly distributed in the polyester residue, with the polyesterpolycarbonates of formula (I) having an intrinsic viscosity of greater than 0.45 dl/g when measured in chloroform at 32.degree. C.
    Type: Grant
    Filed: June 24, 1996
    Date of Patent: December 16, 1997
    Assignee: ASTA Medica Aktiengesellschaft
    Inventors: Paolo Ferruti, Maurizio Penco, Elisabetta Ranucci, Fabio Bignotti
  • Patent number: 5463012
    Abstract: Polycarbonates of formula (I) wherein a is an integer from 2 to 300; R.sup.1 and R.sup.2 are the same or different and are independently a polyester residue of formula (III) wherein x and y are integers from 1 to 50, R.sup.4 and R.sup.5, which are the same or different, are aliphatic straight or branched hydrocarbon chains having from 1 to 4 carbon atoms, R.sup.6 is an aliphatic or alicyclic straight or branched chain having from 2 to 18 carbon atoms, or a polyoxyalkylene residue of formula (II), the two groups --R.sup.4 --COO and --R.sup.5 --COO being randomly distributed in the polyester residue, x and y being in any possible ratio from 0 to 100, are synthesized by reacting dihydroxy compounds with 1,1'-carbonyldiimidazole. They are useful for the preparation of bioerosible matrices for biologically active compounds.
    Type: Grant
    Filed: December 13, 1993
    Date of Patent: October 31, 1995
    Assignee: Mediolanum Farmaceutici S.p.A.
    Inventors: Paolo Ferruti, Elisabetta Ranucci, Fabio Bignotti